Expression of concern
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
Paper Information
Record ID:
34204
Author(s):
Journal:
Publication Date:
August 14, 2020
Retraction Date:
October 11, 2021
(4.1 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt
- Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Internal Medicine, Ain-Shams University, Cairo, Egypt
- Public Health and Community Medicine, Menoufia University, Menoufia, Egypt
- Department of Forensic Medicine and Toxicology, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Internal Medicine, Al-Azhar University, Cairo, Egypt
Country:
🇪🇬 EgyptArticle Type:
Publisher:
American Society of Tropical Medicine and Hygiene
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.4269/ajtmh.20-0873Citations (137)
137
Total Citations45
Post-Retraction(32.8%)
92
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
28
Within 1 year
4
After 2+ years
1294
Days since retraction (latest)
Randomized Controlled Trials on COVID-19 Should Be Accurate and Trustworthy
Ben W. Mol
American Journal of Tropical Medicine and Hygiene
Open Access
Published: Aug 2021
1 citation
1 citation
42 days before retraction
Response to “Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy”
Sherief Abd‐Elsalam, Shaimaa Soliman
American Journal of Tropical Medicine and Hygiene
Open Access
Published: Aug 2021
1 citation
1 citation
42 days before retraction
Compounders of the COVID crisis: the “perfect storm”
Barry A. Franklin
Baylor University Medical Center Proceedings
Open Access
Published: Aug 2021
6 citations
6 citations
49 days before retraction
Enough with the madness: a systematic review and meta-analysis of hydroxychloroquine for COVID-19
A. P. P. dos Santos, Érica Gonçalves, Ananda Oliveira et al. (6 authors)
Jornal Brasileiro de Economia da Saúde
Open Access
Published: Aug 2021
52 days before retraction
Antirheumatic drugs and COVID-19: frustrations and hopes
E. S. Aronova, Б. С. Белов
Meditsinskiy sovet = Medical Council
Open Access
Published: Aug 2021
1 citation
1 citation
60 days before retraction
Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID‐19: Network meta‐analysis of randomized controlled trials
Gerald Chi, Sahar Memar Montazerin, Jane Lee et al. (7 authors)
Journal of Medical Virology
Open Access
Published: Aug 2021
17 citations
17 citations
63 days before retraction
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi et al. (56 authors)
Infectious Diseases and Therapy
Open Access
Published: Jul 2021
34 citations
34 citations
73 days before retraction
Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality
Kimia Honarmand, J.B. Penn, Arnav Agarwal et al. (19 authors)
Journal of Clinical Epidemiology
Open Access
Published: Jul 2021
15 citations
15 citations
88 days before retraction
Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta‐analysis
Tejpal Gupta, Prafulla Thakkar, Babusha Kalra et al. (4 authors)
Reviews in Medical Virology
Open Access
Published: Jul 2021
8 citations
8 citations
93 days before retraction
Acyclovir as a Potential Adjuvant Therapy in COVID-19 Treatment Regimens
Fatemeh Heidary, Sedigheh Madani, Reza Gharebaghi et al. (4 authors)
Pharmaceutical Sciences
Open Access
Published: Jul 2021
9 citations
9 citations
95 days before retraction
RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study
Mahmoud El‐Bendary, Sherief Abd‐Elsalam, Tamer Elbaz et al. (17 authors)
Expert Review of Anti-infective Therapy
Published: Jul 2021
35 citations
35 citations
97 days before retraction
Abstracts for reports of randomized trials of COVID-19 interventions had low quality and high spin
Dongguang Wang, Lingmin Chen, Lian Wang et al. (10 authors)
Journal of Clinical Epidemiology
Open Access
Published: Jul 2021
16 citations
16 citations
100 days before retraction
Hydroxychloroquine for Treatment of COVID‐19 Patients: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Vinícius Ynoe de Moraes, Alexandre R. Marra, Leandro Luongo de Matos et al. (7 authors)
Research Square (Research Square)
Open Access
Published: Jun 2021
117 days before retraction
Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials
Augusto Di Castelnuovo, Simona Costanzo, Antonio Cassone et al. (6 authors)
Pathogens and Global Health
Open Access
Published: Jun 2021
15 citations
15 citations
118 days before retraction
Impacto del confinamiento por COVID-19 en la calidad de vida y salud mental
Catherin L. Ballena, Luis Cabrejos, Yheraldine Dávila et al. (7 authors)
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Open Access
Published: Jun 2021
34 citations
34 citations
124 days before retraction
Antibacterial agents used in COVID-19: A systematic review and meta-analysis
Swati Sharma, Aradhana Singh, Tuhina Banerjee
Environmental Sustainability
Open Access
Published: Jun 2021
10 citations
10 citations
126 days before retraction
Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials
Bahman Amani, Ahmad Khanijahani, Behnam Amani
Scientific Reports
Open Access
Published: Jun 2021
22 citations
22 citations
126 days before retraction
Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis
Adrían V. Hernández, Mi T. Phan, Jonathon Rocco et al. (8 authors)
Journal of Clinical Medicine
Open Access
Published: Jun 2021
12 citations
12 citations
128 days before retraction
Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study
Sherief Abd‐Elsalam, Rasha A. Abdel Noor, Rehab Badawi et al. (16 authors)
Journal of Medical Virology
Open Access
Published: Jun 2021
97 citations
97 citations
131 days before retraction
Response of forensic scientific community to Covid-19 pandemic: A Review Article
M Bogusz
Arab Journal of Forensic Sciences and Forensic Medicine
Open Access
Published: Jun 2021
132 days before retraction
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study
Peter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf et al. (21 authors)
International Journal of Infectious Diseases
Open Access
Published: Jun 2021
5 citations
5 citations
132 days before retraction
COVID-19 - O VÍRUS QUE MOVIMENTOU A CIÊNCIA - VOLUME 1
Priscilla Dantas Almeida, Telma Maria Evangelista de Araújo, Socorro Adriane de S Meneses Brandão et al. (100 authors)
Editora Pasteur eBooks
Open Access
Published: May 2021
136 days before retraction
Antiviral treatment selection for SARS-CoV-2 pneumonia
Matteo Bassetti, Silvia Corcione, Silvia Dettori et al. (9 authors)
Expert Review of Respiratory Medicine
Open Access
Published: May 2021
6 citations
6 citations
155 days before retraction
Utility of Lung Ultrasound in Decision-making to Prioritize Hospital Admission for COVID-19 Patients: A Developing Country Perspective
Samy Zaky, Mohamed A. Metwally, Mohamed El Badry et al. (29 authors)
Current Medical Imaging Formerly Current Medical Imaging Reviews
Published: May 2021
3 citations
3 citations
155 days before retraction
Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis
Sih‐Han Liao, Chien‐Ching Hung, Chiung‐Nien Chen et al. (7 authors)
Journal of the Formosan Medical Association
Open Access
Published: May 2021
5 citations
5 citations
160 days before retraction
An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
Álvaro Réa-Neto, Rafaella Stradiotto Bernardelli, Bruna Martins Dzivielevski Câmara et al. (6 authors)
Scientific Reports
Open Access
Published: Apr 2021
53 citations
53 citations
167 days before retraction
Uso de antirreumáticos en covid-19 desde la hidroxicloroquina hasta la anakinra pasando por tocilizumab y baricitinib: Una revisión de la literatura
Rosa Alejandra Salas-Bolaños, David Ezequiel Sevilla-Rodriguez, Abel Salvador Arroyo-Sánchez
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Open Access
Published: Apr 2021
167 days before retraction
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. (18 authors)
JAMA Network Open
Open Access
Published: Apr 2021
130 citations
130 citations
172 days before retraction
Are countries’ precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide
Thamir M. Alshammari, Khalidah A. Alenzi, Fatemah A. Alnofal et al. (5 authors)
Saudi Pharmaceutical Journal
Open Access
Published: Apr 2021
11 citations
11 citations
173 days before retraction
The therapeutic effect and safety of the drugs for COVID-19
Rong Qiu, Jingwei Li, Yuxuan Xiao et al. (9 authors)
Medicine
Open Access
Published: Apr 2021
5 citations
5 citations
173 days before retraction
SUMMARY OF CONTACT WITH DR. MARIK. PULMONARY MEDICINE AND CRITICAL CARE. EASTERN VIRGINIA MEDICAL SCHOOL - USA.
Luis De Boni
Journal of Law Public Policies and Human Sciences
Open Access
Published: Apr 2021
174 days before retraction
How COVID-19 has fundamentally changed clinical research in global health
Jay Park, Robin Mogg, Gerald E. Smith et al. (11 authors)
The Lancet Global Health
Open Access
Published: Apr 2021
187 citations
187 citations
178 days before retraction
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud et al. (94 authors)
Nature Communications
Open Access
Published: Apr 2021
278 citations
278 citations
179 days before retraction
COVID-19: Antiviral Therapy
Gülruhsar YILMAZ
SDÜ Tıp Fakültesi Dergisi
Open Access
Published: Apr 2021
1 citation
1 citation
189 days before retraction
COVID-19 in Pediatrics: A Diagnostic Challenge
Amal Ahmed Mohamed, Nouran Mohamed, Sherief Abd‐Elsalam et al. (8 authors)
Current Pediatric Reviews
Published: Mar 2021
3 citations
3 citations
195 days before retraction
Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights
Ankit Jain, Shiv Kumar Prajapati, Madhavi Tripathi et al. (5 authors)
Expert Review of Clinical Pharmacology
Published: Mar 2021
6 citations
6 citations
199 days before retraction
Current evidence for COVID-19 therapies: a systematic literature review
Tobias Welte, Lucy Ambrose, Gillian C. Sibbring et al. (6 authors)
European Respiratory Review
Open Access
Published: Mar 2021
48 citations
48 citations
208 days before retraction
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials
Nida Bokharee, Yusra Habib Khan, Aisha Khokhar et al. (6 authors)
Expert Review of Anti-infective Therapy
Published: Mar 2021
10 citations
10 citations
210 days before retraction
Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Sophie Juul, Emil Eik Nielsen, Joshua Feinberg et al. (15 authors)
PLoS ONE
Open Access
Published: Mar 2021
45 citations
45 citations
214 days before retraction
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne et al. (19 authors)
European Respiratory Journal
Open Access
Published: Mar 2021
205 citations
205 citations
215 days before retraction
Self-Reported Symptoms in a Cohort of Rheumatoid Arthritis and Systemic Lupus Erythematosus during the COVID-19 Quarantine Period
Evelyn O. Salido, Cherica Tee, Patrick Wincy C. Reyes et al. (6 authors)
The Open Rheumatology Journal
Open Access
Published: Mar 2021
4 citations
4 citations
223 days before retraction
Recomendaciones para el estudio y manejo farmacológico en pacientes adultos con sospecha de infección por SARS-CoV-2 (COVID-19) Documento conjunto de Sociedad Chilena de Infectología, Sociedad Chilena de Medicina Intensiva y Sociedad Chilena de Enfermedades Respiratorias. Octubre 2020
Jorge Pérez, Ruth Rosales, Fernando Bernal et al. (19 authors)
Revista chilena de enfermedades respiratorias
Open Access
Published: Mar 2021
1 citation
1 citation
224 days before retraction
Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis
Jogender Kumar, Siddharth Jain, Jitendra Meena et al. (4 authors)
Journal of Infection and Chemotherapy
Open Access
Published: Feb 2021
24 citations
24 citations
230 days before retraction
COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention
Ashif Iqubal, Mohammad Kashif Iqubal, Farazul Hoda et al. (5 authors)
Expert Review of Anti-infective Therapy
Open Access
Published: Feb 2021
20 citations
20 citations
230 days before retraction
Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
Zakariya Kashour, Tarek Kashour, Dana Gerberi et al. (4 authors)
Clinical and Translational Science
Open Access
Published: Feb 2021
10 citations
10 citations
234 days before retraction
The Rheumatology Drugs for COVID-19 Management: Which and When?
Fabiola Atzeni, Ignazio Francesco Masala, Javier Rodríguez‐Carrio et al. (11 authors)
Journal of Clinical Medicine
Open Access
Published: Feb 2021
24 citations
24 citations
237 days before retraction
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
Alessia Alunno, Aurélie Najm, Xavier Mariette et al. (8 authors)
Annals of the Rheumatic Diseases
Open Access
Published: Feb 2021
38 citations
38 citations
238 days before retraction
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo et al. (5 authors)
Cochrane library
Open Access
Published: Feb 2021
193 citations
193 citations
241 days before retraction
Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials
Paulo Roberto Bignardi, Carolina Santos Vengrus, Bruno Matos Aquino et al. (4 authors)
Pathogens and Global Health
Open Access
Published: Feb 2021
22 citations
22 citations
242 days before retraction
Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics
Hyung Muk Choi, Soo Youn Moon, Hyung In Yang et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Feb 2021
22 citations
22 citations
244 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #39037
Sep 02, 2022Quick Stats
Total Citations:
137
Years Since Retraction:
4.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025